Director Shareholding

GlaxoSmithKline PLC
10 January 2002


                             Director's Interests

I give below details of changes in interests in the Ordinary Share ADRs of
GlaxoSmithKline plc (each ADR represents two Ordinary Shares) in respect of
the under-mentioned director arising from the purchase of Ordinary Share ADRs
on 3 January 2002 from the reinvestment of the dividend paid to Ordinary Share
ADR holders on the 3 January 2002 through the US Global BuyDirect Plan
administered by The Bank of New York:-

Mr D F     Beneficial interest in 0.2262 of an Ordinary Share ADR purchased at
McHenry    a price of $49.9887 per ADR.


Mr McHenry and the Company were advised of this information on 9 January 2002.


S M Bicknell

Company Secretary

10 January 2002